These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3043443)

  • 21. Dynamic changes of adiponectin and S100A8 levels by the selective peroxisome proliferator-activated receptor-gamma agonist rivoglitazone.
    Hiuge-Shimizu A; Maeda N; Hirata A; Nakatsuji H; Nakamura K; Okuno A; Kihara S; Funahashi T; Shimomura I
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):792-9. PubMed ID: 21233451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoglycemic and hypolipidemic effects of Coriandrum sativum L. in Meriones shawi rats.
    Aissaoui A; Zizi S; Israili ZH; Lyoussi B
    J Ethnopharmacol; 2011 Sep; 137(1):652-61. PubMed ID: 21718774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Thiazolidinediones: effect of the pioglitazone on hyperglycemia, dyslipidemia and cardiovascular risk].
    Tan MH
    Rev Clin Esp; 2003 Jan; 203(1):33-40. PubMed ID: 12605799
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of troglitazone on insulin sensitivity.
    Henry RR
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S148-50. PubMed ID: 8894499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral green tea catechins transiently lower plasma glucose concentrations in female db/db mice.
    Wein S; Schrader E; Rimbach G; Wolffram S
    J Med Food; 2013 Apr; 16(4):312-7. PubMed ID: 23514230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ciglitazone, a new hypoglycaemic agent. 3. Effect on glucose disposal and gluconeogenesis in vivo in C57BL/6J-ob/ob and -+/? mice.
    Chang AY; Gilchrist BJ; Wyse BM
    Diabetologia; 1983 Dec; 25(6):514-20. PubMed ID: 6662280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone.
    Tack CJ; Ong MK; Lutterman JA; Smits P
    Diabetologia; 1998 May; 41(5):569-76. PubMed ID: 9628275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
    Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
    Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations of the classic pathway of complement in adipose tissue of obesity and insulin resistance.
    Zhang J; Wright W; Bernlohr DA; Cushman SW; Chen X
    Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1433-40. PubMed ID: 17244723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoglycemic activity of a series of alpha-alkylthio and alpha-alkoxy carboxylic acids related to ciglitazone.
    Hulin B; Newton LS; Lewis DM; Genereux PE; Gibbs EM; Clark DA
    J Med Chem; 1996 Sep; 39(20):3897-907. PubMed ID: 8831756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age-Dependent Onset of Insulin Resistance in Insulin-Resistant Mice.
    Ide N; Arisawa K; Ogura K; Kagawa Y; Maeda T
    Biol Pharm Bull; 2015; 38(12):1925-34. PubMed ID: 26632184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic improvement in insulin resistance with a combination of fenofibrate and rosiglitazone in obese type 2 diabetic mice.
    Choi WS; Lee JJ; Kim Y; Kim IS; Zhang WY; Myung CS
    Arch Pharm Res; 2011 Apr; 34(4):615-24. PubMed ID: 21544727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Causal therapy of type 2 diabetes. Determining the cause of insulin resistance early].
    MMW Fortschr Med; 2000 Nov; 142(47):56. PubMed ID: 11143782
    [No Abstract]   [Full Text] [Related]  

  • 34. Perfluorocarbon-based antidiabetic agents.
    Kees KL; Smith TM; McCaleb ML; Prozialeck DH; Cheeseman RS; Christos TE; Patt WC; Steiner KE
    J Med Chem; 1992 Mar; 35(5):944-53. PubMed ID: 1548684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats.
    Kramer D; Shapiro R; Adler A; Bush E; Rondinone CM
    Metabolism; 2001 Nov; 50(11):1294-300. PubMed ID: 11699047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired expression and functional activity of the beta 3- and beta 1-adrenergic receptors in adipose tissue of congenitally obese (C57BL/6J ob/ob) mice.
    Collins S; Daniel KW; Rohlfs EM; Ramkumar V; Taylor IL; Gettys TW
    Mol Endocrinol; 1994 Apr; 8(4):518-27. PubMed ID: 7914350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats.
    Sugiyama Y; Taketomi S; Shimura Y; Ikeda H; Fujita T
    Arzneimittelforschung; 1990 Mar; 40(3):263-7. PubMed ID: 2189419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihyperglycemic activity of novel substituted 3H-1,2,3,5-oxathiadiazole 2-oxides.
    Ellinboe JW; Alessi TR; Dolak TM; Nguyen TT; Tomer JD; Guzzo F; Bagli JF; McCaleb ML
    J Med Chem; 1992 Apr; 35(7):1176-83. PubMed ID: 1560432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals.
    Ikeda H; Taketomi S; Sugiyama Y; Shimura Y; Sohda T; Meguro K; Fujita T
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):156-62. PubMed ID: 2334455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adipose mitochondrial biogenesis is suppressed in db/db and high-fat diet-fed mice and improved by rosiglitazone.
    Rong JX; Qiu Y; Hansen MK; Zhu L; Zhang V; Xie M; Okamoto Y; Mattie MD; Higashiyama H; Asano S; Strum JC; Ryan TE
    Diabetes; 2007 Jul; 56(7):1751-60. PubMed ID: 17456854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.